Cormorant Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $400K | Sell |
|
|||||
|
2020
Q4 | $680K | Sell |
|
|||||
|
2020
Q3 | $830K | Sell |
|
|||||
|
2020
Q2 | $2.9M | Sell |
|
|||||
|
2020
Q1 | $2.68M | Sell |
|
|||||
|
2019
Q4 | $4.32M | Sell |
|
|||||
|
2019
Q3 | $14.4M | Buy |
|
|||||
|
2019
Q2 | $14.2M | Sell |
|
|||||
|
2019
Q1 | $16.8M | Sell |
|
|||||
|
2018
Q4 | $18M | Sell |
|
|||||
|
2018
Q3 | $83.5M | Sell |
|
|||||
|
2018
Q2 | $73.2M | Sell |
|
|||||
|
2018
Q1 | $272M | Buy |
|
|||||
|
2017
Q4 | $119M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $28.8M | Buy |
|
|||||
|
2016
Q1 | $27.5M | Buy |
|
|||||
|
2015
Q4 | $12.9M | Buy |
|
|||||
|
2015
Q3 | $4.36M | Hold |
|
|||||
|
2015
Q2 | $4.97M | Hold |
|
|||||
|
2015
Q1 | $4.37M | Sell |
|
|||||
|
2014
Q4 | $6.97M | Hold |
|
|||||
|
2014
Q3 | $5.43M | Buy |
|